Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial-Reference-Cited by-同舟云学术

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

Published:2015-05 Issue:9980 Volume:385 Page:1863-1872
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Del Mastro Lucia,De Placido Sabino,Bruzzi Paolo,De Laurentiis Michele,Boni Corrado,Cavazzini Giovanna,Durando Antonio,Turletti Anna,Nisticò Cecilia,Valle Enrichetta,Garrone Ornella,Puglisi Fabio,Montemurro Filippo,Barni Sandro,Ardizzoni Andrea,Gamucci Teresa,Colantuoni Giuseppe,Giuliano Mario,Gravina Adriano,Papaldo Paola,Bighin Claudia,Bisagni Giancarlo,Forestieri Valeria,Cognetti Francesco

Publisher

Elsevier BV

Subject

General Medicine

Reference21 articles.

1. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials;Peto;Lancet,2012

2. Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313);Linden;J Clin Oncol,2007

3. Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer;Kümmel;Br J Cancer,2006

4. Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study;Moebus;J Clin Oncol,2010

5. Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial;Swain;J Clin Oncol,2013

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial;Journal of Clinical Oncology;2024-09-10

2. Cost of Pegfilgrastim for the Prophylaxis of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer Receiving Perioperative Chemotherapy in Daily Practice in Japan: A Posthoc Analysis in a Single-center Retrospective Study;YAKUGAKU ZASSHI;2024-09-01

3. Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial;ESMO Open;2024-08

4. Association of oral mucositis induced by anthracycline-cyclophosphamide and subsequent docetaxel treatment for perioperative breast cancer;Supportive Care in Cancer;2024-07-13

5. Gender minorities in breast cancer – Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients;The Breast;2024-06